tiprankstipranks

Paul Clancy Insider Profile

4 Followers
Paul Clancy, EVP & CFO at Biogen, holds 15.79K shares in Incyte (Ticker: INCY), holds 14.70K shares in Exact Sciences (Ticker: EXAS), holds 6.55K shares in Agios Pharma (Ticker: AGIO).
tipranks
Paul Clancy

Paul Clancy
Biogen (BIIB)
EVP & CFO

Ranked #49,658 out of 98,624 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-0.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
71.13%
13.24%
12.48%
3.15%
0.00% Others
A breakdown of Paul Clancy's holdings

Insider Roles

Biogen
(BIIB)
EVP & CFO
Exact Sciences
(EXAS)
Director
Incyte
(INCY)
Director
Agios Pharma
(AGIO)
Director
+1 other positions
Roles that Paul Clancy holds in companies

Most Profitable Insider Trade

Stock:
Alexion Pharmaceuticals
(ALXN)
Rating:Informative Sell
Date:Jul 12, 2018 - Jul 12, 2019
Return:+10.00%
The most profitable trade made by Paul Clancy

Paul Clancy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Apr 27, 2017
EVP & CFO
Uninformative Sell
2.87M
$4.65M
ALXN
Alexion Pharmaceuticals
Jul 15, 2019
Uninformative Sell
649.57K
$16.51M
Exact Sciences
Jun 12, 2023
Director
Uninformative Buy
$865.15K
Xilio Therapeutics
Director
Incyte
Apr 02, 2024
Director
Uninformative Buy
22.96K
$815.77K
Agios Pharma
May 24, 2022
Director
Uninformative Buy
$206.23K
List of latest transactions for each holding click on a transaction to see Paul Clancy's performance on stock

Paul Clancy insider profile FAQ

What is the percentage of profitable transactions made by Paul Clancy?
The percentage of profitable transactions made by Paul Clancy is 50%.
    What is the average return per transaction made by Paul Clancy?
    The average return per transaction made by Paul Clancy is -0.30%.
      What stocks does Paul Clancy hold?
      Paul Clancy holds: BIIB, ALXN, EXAS, XLO, INCY, AGIO stocks.
        What was Paul Clancy’s latest transaction?
        Paul Clancy latest transaction was an Uninformative Buy of $22.96K.
          What was Paul Clancy's most profitable transaction?
          Paul Clancy’s most profitable transaction was an Informative Sell of ALXN stock on July 12, 2018. The return on the trade was 10.00%.
            What is Paul Clancy's role in Biogen?
            Paul Clancy's role in Biogen is EVP & CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.